First Time Loading...

Fagron NV
XBRU:FAGR

Watchlist Manager
Fagron NV Logo
Fagron NV
XBRU:FAGR
Watchlist
Price: 18.8 EUR -0.42%
Updated: May 21, 2024
Section:
 

Relative Value

The Relative Value of one FAGR stock under the Base Case scenario is 27.31 EUR. Compared to the current market price of 18.8 EUR, Fagron NV is Undervalued by 31%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

FAGR Relative Value
Base Case
27.31 EUR
Undervaluation 31%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.8
P/S
P/S
Price to Sales
1.8
vs History
36
vs Industry
53
Median 3Y
1.7
Median 5Y
1.7
Industry
2.4
Forward
1.6
More Details
19.5
P/E
P/E
Price to Earnings
19.5
vs History
30
vs Industry
30
Median 3Y
17.9
Median 5Y
17.5
Industry
24.1
Forward
16.8
More Details
11
P/OCF
P/OCF
Price to OCF
11
vs History
66
vs Industry
34
Median 3Y
11
Median 5Y
13.8
Industry
16
More Details
50.1
P/FCFE
P/FCFE
Price to FCFE
50.1
vs History
20
vs Industry
13
Median 3Y
44.4
Median 5Y
26.7
Industry
23.1
More Details
3
P/B
P/B
Price to Book Value
3
vs History
65
vs Industry
31
Median 3Y
2.9
Median 5Y
4
Industry
2.3
More Details
2.1
EV/S
EV/S
Enterprise Value to Sales
2.1
vs History
46
vs Industry
49
Median 3Y
2.1
Median 5Y
2
Industry
2.5
Forward
1.9
More Details
4.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.8
vs History
47
vs Industry
47
Median 3Y
4.9
Median 5Y
4.8
Industry
5.3
More Details
10.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.9
vs History
50
vs Industry
32
Median 3Y
11.2
Median 5Y
11
Industry
13.1
Forward
9.4
More Details
14.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
14.3
vs History
44
vs Industry
32
Median 3Y
14.4
Median 5Y
14.1
Industry
17.8
Forward
12.4
More Details
12.8
EV/OCF
EV/OCF
Enterprise Value to OCF
12.8
vs History
76
vs Industry
33
Median 3Y
13.5
Median 5Y
16.4
Industry
15.5
More Details
18.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
18.5
vs History
61
vs Industry
26
Median 3Y
18
Median 5Y
20.5
Industry
19.7
More Details
2.1
EV/IC
EV/IC
Enterprise Value to IC
2.1
vs History
55
vs Industry
38
Median 3Y
2
Median 5Y
2.2
Industry
2
More Details

Multiples Across Competitors

FAGR Competitors Multiples
Fagron NV Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
BE
Fagron NV
XBRU:FAGR
1.4B EUR 1.8 19.5 10.9 14.3
US
Mckesson Corp
NYSE:MCK
72.5B USD 0.2 24.3 16.3 18.9
US
Cencora Inc
NYSE:COR
44.1B USD 0.2 23.8 11.7 16.4
US
Amerisourcebergen Corp
NYSE:ABC
35.4B USD 0.1 20.9 11.3 15.2
US
Cardinal Health Inc
NYSE:CAH
23.6B USD 0.1 43.1 8.9 11.9
US
Henry Schein Inc
NASDAQ:HSIC
9.4B USD 0.8 24.3 12.4 17.5
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
CN
Sinopharm Group Co Ltd
HKEX:1099
66.9B HKD 0.1 6.9 1.7 2.1
IT
Amplifon SpA
MIL:AMP
7.5B EUR 3.3 46.9 15.2 30.3
CN
Huadong Medicine Co Ltd
SZSE:000963
57.5B CNY 1.4 19.5 14.9 14.9
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
52B CNY 0.2 13.7 8.5 8.5

See Also

Summary
FAGR intrinsic value, competitors valuation, and company profile.
DCF Valuation
FAGR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
FAGR stock valuation using valuation multiples.
Wall Street Estimates
FAGR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
FAGR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 139,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.